Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multivariate pharmaceutical profiling for drug discovery.

Edward H Kerns1, Li Di

  • 1Wyeth-Ayerst Research, Chemical Sciences, Princeton, NJ 08543-8000, USA. kernse@war.wyeth.com

Current Topics in Medicinal Chemistry
|March 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and Safety.

CNS neuroscience & therapeutics·2026
Same author

Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK Analysis.

The AAPS journal·2026
Same author

Clinical and laboratory features of juvenile-onset anti-NF155 autoimmune nodopathy.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.

Journal of neurology·2026
Same author

Absorption, distribution, metabolism, and excretion tactics toward the expedited discovery and development of the severe acute respiratory syndrome coronavirus-2 main protease inhibitor nirmatrelvir.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Effects of Thymectomy in Late-Onset Myasthenia Gravis: A Multi-Center Longitudinal Retrospective Study.

Annals of neurology·2025
Same journal

Cosmetic Products Containing Rutin: A Systematic Review of Patents from 2014 to 2024.

Current topics in medicinal chemistry·2026
Same journal

Overview of Immunotherapy in Lung Cancer: Present Landscape.

Current topics in medicinal chemistry·2026
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
See all related articles

Pharmaceutical profiling assays assess drug properties early in discovery. This optimizes drug candidate selection, reducing failures and saving resources in new drug development.

Area of Science:

  • Drug discovery and development
  • Medicinal chemistry
  • Pharmacology

Background:

  • Pharmaceutical properties critically influence drug efficacy and safety.
  • Inadequate drug properties are a major cause of failure in drug discovery and development.
  • Early assessment of drug properties is essential to mitigate risks and resource loss.

Purpose of the Study:

  • To describe the field of pharmaceutical profiling in drug discovery.
  • To highlight the importance of pharmaceutical profiling assays.
  • To discuss strategies and data management in pharmaceutical profiling.

Main Methods:

  • Implementation of pharmaceutical profiling assays.
  • Measurement of drug candidate properties at early discovery stages.

Related Experiment Videos

  • Data analysis for informed decision-making.

    • Main Results:

    • Pharmaceutical profiling enables measurement of drug properties.
    • Informed decisions regarding drug candidate selection and optimization.
    • Emergence of holistic parallel activity and property optimization processes.

    Conclusions:

    • Pharmaceutical profiling is crucial for successful drug discovery.
    • Early and continuous assessment of drug properties improves development outcomes.
    • Integrated strategies enhance the efficiency of identifying viable drug candidates.